The aim of this study is to evaluate the effectiveness and safety of continuous subcutaneous insulin infusion (CSII) under real-life conditions among all patients treated with CSII in the south of Paris.
Service de diabétologie, centre hospitalier sud-francilien, 59, boulevard Henri-Dunant, 91600 Corbeil-Essonnes, France. jeanpierre.riveline@ch-sud-francilien.fr <jeanpierre.riveline@ch-sud-francilien.fr>